Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - Science, 2022 - science.org
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …
被引用次数：126 相关文章
[HTML] europepmc.org

[HTML][HTML] Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - 2021 - europepmc.org
Abstract With B. 1.1. 529 SARS-CoV-2 variant's rapid spread and substantially increased
resistance to neutralization by vaccinee and convalescent sera, monoclonal antibodies with …

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - bioRxiv, 2021 - biorxiv.org
Abstract With B. 1.1. 529 SARS-CoV-2 variant's rapid spread and substantially increased
resistance to neutralization by vaccinee and convalescent sera, monoclonal antibodies with …

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529.

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - 2022 - cabidigitallibrary.org
INTRODUCTION: The emergence and rapid spread of the B. 1.1. 529 (Omicron) variant of
concern (VOC) with 37 mutations in the spike protein has raised alarm. Especially …

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - Science, 2022 - cir.nii.ac.jp
抄録< jats: p> The rapid spread of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) B. 1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee …
[PDF] scienceopen.com

[PDF][PDF] Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - scienceopen.com
The rapid spread of the SARS-CoV-2 B. 1.1. 529 (Omicron) variant and its resistance to
neutralization by vaccinee and convalescent sera are driving a search for monoclonal …
[HTML] nih.gov

[HTML][HTML] Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang… - Science (New York …, 2022 - ncbi.nlm.nih.gov
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - 2021 - pesquisa.bvsalud.org
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 |
PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Structural basis for potent antibody neutralization …

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu… - … (New York, NY), 2022 - pubmed.ncbi.nlm.nih.gov
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …
[PDF] archive.org

[PDF][PDF] Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B. 1.1. 529

T Zhou, L Wang, J Misasi, A Pegu, Y Zhang, DR Harris… - scholar.archive.org
Abstract With B. 1.1. 529 SARS-CoV-2 variant's rapid spread and substantially increased
resistance to neutralization by vaccinee and convalescent sera, monoclonal antibodies with …